Technical Program | AIChE

Technical Program

Technical Program for AccBio 2023

 

To View Abstracts for AccBio Conference please CLICK HERE 

...

Read more

Start Time End Time  
September 6, 2023 All Eastern Standard Time
    Day 1
1:00 PM 4:00 PM Registration
2:00 PM 2:10 PM Conference Introduction by Chairs: Ganesh Vedantham, Biomarin &  Glen Bolton, Amgen
2:10 PM 2:50 PM KEYNOTE: In pursuit of Africa’s health Security: Building strategic capabilities in South Africa to facilitate broader access to vaccines and biologics on the continent, Rachel Chikwamba, CSIR
2:50 PM 3:20 PM Afternoon Coffee Break Sponsored by Takeda
3:20 PM 4:00 PM KEYNOTE: Answering pressing questions about Gene Therapy to enable transformative medicine, Kevin Eggan, BioMarin,
4:00 PM 5:00 PM Poster Session hosted by NIIMBL and Cocktail Reception hosted by 3M
     
Start Time End Time  
9/7/2023 All Eastern Standard Time
    Day 2
7:00 AM 4:00 PM Registration
7:30 AM 8:00 AM Breakfast 
8:00 AM 8:10 AM Day 2 Welcome and Introduction by Chairs: Ganesh Vedantham, Biomarin &  Glen Bolton, Amgen
8:10 AM 8:50 AM KEYNOTE: Multispecificity – The Future of Molecular Medicines, Raymond Deshaies, Amgen
8:50 AM 9:00 AM Stretch Break
9:00 AM 12:45 PM Session 1: Enduring Lessions Learned from the Pandemic
9:00 AM 9:05 AM Introduction by Session Chairs: Greg Naugle, GSK and Jeff Salm, Pfizer
9:05 AM 9:30 AM CMC Strategies for Accelerated Development of Complex Biologics for Unmet Medical Needs from an
Analytical Perspective,
Qian Wang, Pfizer,
9:30 AM 9:55 AM Enduring effects from the pandemic: Innovation in drug delivery, Rubi Burlage, Merck
9:55 AM 10:20 AM Process Validation in a Pandemic, David Robbins, AstraZeneca
10:20 AM 10:50 AM Morning Coffee Break 
10:50 AM 11:15 AM Lessons in Speed from the Pandemic: Preclinical Development and Company Collaboration, John Mattila, Regeneron
11:15 AM 11:40 AM Collaboration with a competitor: A pandemic success story between Lilly and Amgen, Myrta Atiles, Amgen
11:40 AM 12:40 PM Q&A Panel Discussion
12:40 PM 12:45 PM Closing Remarks by Session Chair: Greg Naugle, GSK
12:45 PM 1:45 PM Lunch 
1:45 PM 5:40 PM Session 2: Accelerating Development Using Predictive Technologies 
1:45 PM 1:50 PM Introduction by Session Chairs: Rohini Deshpande, Amgen and Raghu Shivappa, Takeda
1:50 PM 2:10 PM Using Stability Prior Knowledge from ‘Like-molecules’ to Establish Shelf-life and Accelerate Product Development, Barbara Rellahan, Amgen
2:10 PM 2:30 PM Digital Thread Centric IOT Data to Break Down Data Silos, Shanti Chari, Landmark Bio
2:30 PM 2:50 PM Research in-silico modeling/predictions and experimental work, Trevor Swartz, Genentech
2:50 PM 3:10 PM Transforming Upstream Process Development through Implementation of Predictive Models, Jackie Gonzalez, Takeda 
3:10 PM 3:30 PM Centralizing Lab and Process Data -- Challenges for Connecting and Modeling Bioprocessing Data, Jason Hirshman, Uncountable
3:30 PM 4:00 PM Afternoon Coffee Break Sponsored by Lilly
4:00 PM 4:20 PM Implementation of an Online PAT Co-Laboratory for Accelerating Process Development, Katrina Janiszewski, Takeda
4:20 PM 4:40 PM Smart Process Analytics for the End-to-End Batch Manufacturing of Monoclonal Antibodies, Richard Braatz, MIT
4:40 PM 5:40 PM Q&A Panel Discussion 
5:40 PM 6:40 PM Cocktail Reception Sponsored by Pfizer 
     
Start Time End Time  
9/8/2023 All Eastern Standard Time
    Day 3
7:00 AM 3:00 PM Registration
7:30 AM 8:00 AM Breakfast 
8:00 AM 8:10 AM Day 3 Welcome and Introduction by Chairs: Ganesh Vedantham, BiomarinGlen Bolton, Amgen
8:10 AM 8:50 AM Keynote Speaker 4: Development speed: what's different for novel modalities, Alison Moore, Allogene
8:50 AM